SABIEDRIBA AR IEROBEZOTU ATBILDIBURIGAS STRADINA UNIVERSITATES STOMATOLOGIJAS INSTITUTS

Their core work

The Stomatology Institute of Riga Stradins University is a dental and oral health research organization affiliated with one of Latvia's leading medical universities. Their core work centers on dental biomaterials — the materials used in implants, prosthetics, bone regeneration, and oral tissue repair. Through participation in the Baltic Biomaterials Centre of Excellence (BBCE), they contribute clinical and applied research expertise in testing and validating biomaterials for dental and broader medical device applications. They sit at the intersection of academic dental medicine and applied materials science, acting as a specialist clinical partner for biomaterials research in the Baltic region.

What they specialise in

How they've shifted over time

The institute's H2020 trajectory is entirely defined by a single project family — BBCE — first entered in a preparatory phase (2017-2018) with no recorded keywords, and then re-entered in a full implementation phase (2020-2027) with explicit focus on biomaterials, medical devices, and centre of excellence development. This suggests the early phase was about scoping and consortium formation, while the recent phase represents active research and infrastructure delivery. The trend is a deepening commitment to the same core topic rather than diversification, which points to a specialist organization consolidating expertise rather than expanding its thematic portfolio.

They are on a long-term (2020-2027) trajectory of deepening dental and medical biomaterials expertise within a Baltic regional excellence cluster — a stable, committed partner for anyone building consortia in oral health, implantology, or materials testing.

How they like to work

This organization has never coordinated an H2020 project — they participate exclusively as a specialist partner, contributing domain expertise rather than managing consortia. Their entire network consists of just 5 unique partners across 3 countries, all within the BBCE project, indicating a tight regional cluster rather than a broad pan-European network. Working with them means engaging a focused specialist who operates within established Baltic partnerships, not a well-networked hub for broad consortium building.

Their collaboration footprint is small and concentrated — 5 partners across 3 countries, all connected through the BBCE Baltic regional network. This reflects a deliberate regional focus rather than pan-European ambition.

What sets them apart

This institute is rare in combining a clinical dental school environment with biomaterials research infrastructure in Latvia — a Widening country where such specialized capacity is scarce and explicitly supported by EU funding. For consortium builders needing a Baltic clinical partner with demonstrated biomaterials validation capabilities, they fill a gap that very few Latvian organizations can. Their long-running involvement in BBCE also signals institutional staying power and genuine technical contribution rather than token geographic inclusion.

Highlights from their portfolio

• BBCE
  The full-phase BBCE project (2020-2027, EUR 1.86M) is one of the largest and longest H2020 Widening investments in Baltic biomaterials infrastructure, positioning this institute as a core node in the region's medical materials research ecosystem.
• BBCE
  The preparatory BBCE phase (2017-2018) shows the institute was involved from the earliest consortium design stage, indicating genuine scientific ownership of the initiative rather than late-added participation.